Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Susan Hilt"'
Autor:
Yingxia Wen, Hung V Trinh, Christine E Linton, Chiara Tani, Nathalie Norais, DeeAnn Martinez-Guzman, Priyanka Ramesh, Yide Sun, Frank Situ, Selen Karaca-Griffin, Christopher Hamlin, Sayali Onkar, Sai Tian, Susan Hilt, Padma Malyala, Rushit Lodaya, Ning Li, Gillis Otten, Giuseppe Palladino, Kristian Friedrich, Yukti Aggarwal, Celia LaBranche, Ryan Duffy, Xiaoying Shen, Georgia D Tomaras, David C Montefiori, William Fulp, Raphael Gottardo, Brian Burke, Jeffrey B Ulmer, Susan Zolla-Pazner, Hua-Xin Liao, Barton F Haynes, Nelson L Michael, Jerome H Kim, Mangala Rao, Robert J O'Connell, Andrea Carfi, Susan W Barnett
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0194266 (2018)
The RV144 Phase III clinical trial with ALVAC-HIV prime and AIDSVAX B/E subtypes CRF01_AE (A244) and B (MN) gp120 boost vaccine regime in Thailand provided a foundation for the future development of improved vaccine strategies that may afford protect
Externí odkaz:
https://doaj.org/article/c524038f512c48a39e68e221debb900c
Autor:
Carlo Zambonelli, Antu K Dey, Susan Hilt, Samuel Stephenson, Eden P Go, Daniel F Clark, Mark Wininger, Celia Labranche, David Montefiori, Hua-Xin Liao, Ronald I Swanstrom, Heather Desaire, Barton F Haynes, Andrea Carfi, Susan W Barnett
Publikováno v:
PLoS ONE, Vol 11, Iss 7, p e0157391 (2016)
The viral envelope glycoprotein (Env) is the major target for antibody (Ab)-mediated vaccine development against the Human Immunodeficiency Virus type 1 (HIV-1). Although several recombinant Env antigens have been evaluated in clinical trials, only t
Externí odkaz:
https://doaj.org/article/3bd711cd04e04af68ea0083b32fc53a5
Autor:
Celia C. LaBranche, Mark Wininger, Andrea Carfi, Barton F. Haynes, Carlo Zambonelli, David C. Montefiori, Heather Desaire, Hua-Xin Liao, Daniel F. Clark, Samuel Stephenson, Eden P. Go, Susan W. Barnett, Susan Hilt, Antu K. Dey, Ronald Swanstrom
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 7, p e0157391 (2016)
PLoS ONE, Vol 11, Iss 7, p e0157391 (2016)
The viral envelope glycoprotein (Env) is the major target for antibody (Ab)-mediated vaccine development against the Human Immunodeficiency Virus type 1 (HIV-1). Although several recombinant Env antigens have been evaluated in clinical trials, only t
Autor:
S Stephenson, Mark Wininger, Susan W. Barnett, Susan Hilt, Carlo Zambonelli, Yingxia Wen, Antu K. Dey, Andrea Carfi
Publikováno v:
Retrovirology, Vol 9, Iss Suppl 2, p P356 (2012)
Retrovirology
Retrovirology
Background Development of an effective vaccine against HIV-1 is challenging due to various viral evolutionary mechanisms to evade human immune system. The partial efficacy of the recent RV144 vaccine efficacy trial in Thailand provides hope for impro
Autor:
Yide Sun, Elaine Kan, Brian Burke, Leonidas Stamatatos, Indresh K. Srivastava, Jimna Cisto, Susan Hilt, Susan W. Barnett, Ying Lian, R. Holland Cheng, Karin Hartog, Jeffrey B. Ulmer, Zohar Biron, Victoria Sharma
Publikováno v:
Virology. 372(2)
We previously reported that an envelope (Env) glycoprotein immunogen (o-gp140DeltaV2SF162) containing a partial deletion in the second variable loop (V2) derived from the R5-tropic HIV-1 isolate SF162 partially protected vaccinated rhesus macaques ag
Autor:
Estrelita Janse van Rensburg, Sunee Himathongkham, Paul A. Luciw, Dietmar Rabussay, Yide Sun, John J. Donnelly, Susan Hilt, Indresh K. Srivastava, David C. Montefiori, Elaine Kan, Gillis R. Otten, Jeffrey B. Ulmer, V. Raúl Gómez-Román, Susan Engelbrecht, Susan W. Barnett, Jan zur Megede, Ying Lian
Human immunodeficiency virus type 1 (HIV-1) subtype C infections are on the rise in Sub-Saharan Africa and Asia. Therefore, there is a need to develop an HIV vaccine capable of eliciting broadly reactive immune responses against members of this subty
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afd02c933601dd24eed2f9ce71bc3359
https://europepmc.org/articles/PMC1262580/
https://europepmc.org/articles/PMC1262580/
Autor:
Shan Lu, John R. Mascola, Leonidas Stamatatos, Clarisa Buckner, Ying Lian, Carl T. Wild, Susan Hilt, Agegnehu Gettie, Louisa Leung, S. Cherpelis, Shixia Wang, Susan W. Barnett, Jeffrey B. Ulmer, J. Blanchard, I. Mboudjeka, A. Fong, A. Ly, Indresh K. Srivastava
Partial deletion of the second hypervariable region from the envelope of the primary-like SF162 virus increases the exposure of certain neutralization epitopes and renders the virus, SF162ΔV2, highly susceptible to neutralization by clade B and non-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74adf882025411e2727b371bdf523eed
https://europepmc.org/articles/PMC114265/
https://europepmc.org/articles/PMC114265/
Autor:
Jeffrey B. Ulmer, R. Holland Cheng, Zohar Biron, Yide Sun, Brian Burke, Indresh K. Srivastava, Victoria Sharma, Karin Hartog, Ruben Diaz-Avalos, Ying Lian, Jimna Cisto, Elaine Kan, Susan W. Barnett, Leonidas Stamatatos, Susan Hilt
Publikováno v:
Virology. 381:287
Corrigendum to “Comparative evaluation of trimeric envelope glycoproteins derived from subtype C and B HIV-1 R5 isolates” [Virology 372 (2008) 273–290] Indresh K. Srivastava ⁎, Elaine Kan , Yide Sun , Victoria A. Sharma , Jimna Cisto , Brian
Autor:
null EDN, Marty Brewster, Joanne S. Gillespie, Jim Burke, Susan Hilt, Kathy Megyeri, Martha Jokela, Dorothy D. Whittle
Publikováno v:
The English Journal. 80:89
Publikováno v:
Sarcoma, Vol 1, Iss 1, Pp 61-63 (1997)
Externí odkaz:
https://doaj.org/article/9aa8d9ceb8d34578ab165e537b446eb5